Clinical Trial Update: Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study

View source ↗

Summary

A completed follow-up clinical trial evaluating adherence and long-term effects of OROS methylphenidate (CONCERTA) in attention-deficit/hyperactivity disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Attention Deficit Disorder With Hyperactivity | Status: COMPLETED